We are live on
!
Find out more
CAM
Cresset Asset Management Portfolio holdings
AUM
$23.1B
1-Year Est. Return
27.04%
This Fund
S&P 500
This Quarter
Est. Return
+13.26%
1 Year Est. Return
+27.04%
3 Year Est. Return
+93.04%
5 Year Est. Return
+103.75%
10 Year Est. Return
–
AUM
$20.1B
AUM Growth
+$63.4M
(+0.32%)
Cap. Flow
-$1.95B
Cap. Flow
% of AUM
-9.72%
Top 10 Holdings %
Top 10 Hldgs %
45.26%
Holding
1,837
New
126
Increased
243
Reduced
946
Closed
408
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EAGL
Eagle Capital Select Equity ETF
EAGL
|
+$105M |
| 2 |
AVUQ
Avantis U.S. Quality ETF
AVUQ
|
+$48.4M |
| 3 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$23.3M |
| 4 |
AllianceBernstein
AB
|
+$12.1M |
| 5 |
Arista Networks
ANET
|
+$11.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$141M |
| 2 |
Apple
AAPL
|
+$138M |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
+$135M |
| 4 |
Blue Owl Capital
OWL
|
+$90.1M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$74.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.58% |
| 2 | Financials | 8.25% |
| 3 | Communication Services | 5.29% |
| 4 | Industrials | 3.09% |
| 5 | Healthcare | 2.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Vanguard FTSE Europe ETF
VGK
$31.4B
| $6.04M | 0.03% |
77,886
-5,541
| -7% | -$409K |
|
302
West Pharmaceutical
WST
$24.9B
| $6.03M | 0.03% |
27,537
-1,033
| -4% | -$221K |
|
303
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.6B
| $6.02M | 0.03% |
148,795
-5,709
| -4% | -$219K |
|
|
SCHV
304
Schwab US Large-Cap Value ETF
SCHV
$16.1B
| $6M | 0.03% |
216,924
-31,297
| -13% | -$823K |
|
305
US Bancorp
USB
$99.6B
| $6M | 0.03% |
131,150
-29,407
| -18% | -$1.24M |
|
306
Gilead Sciences
GILD
$165B
| $5.97M | 0.03% |
53,824
-7,912
| -13% | -$842K |
|
307
VanEck Semiconductor ETF
SMH
$73.2B
| $5.93M | 0.03% |
21,269
+2,144
| +11% | +$497K |
|
308
iShares Russell Top 200 ETF
IWL
$2.28B
| $5.87M | 0.03% |
33,181
+8,450
| +34% | +$1.19M |
|
309
iShares Core Dividend Growth ETF
DGRO
$43.5B
| $5.85M | 0.03% |
91,492
-20,429
| -18% | -$1.25M |
|
310
Stryker
SYK
$130B
| $5.76M | 0.03% |
14,534
-6,779
| -32% | -$2.54M |
|
311
State Street SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
$270M
| $5.66M | 0.03% |
+201,513
| New | +$5.52M |
|
312
Valero Energy
VLO
$85.9B
| $5.66M | 0.03% |
42,074
-3,684
| -8% | -$459K |
|
313
BRC Inc
BRCC
$250M
| $5.63M | 0.03% |
4,297,158
+1,000,000
| +30% | +$1.85M |
|
314
iShares Select U.S. REIT ETF
ICF
$2.09B
| $5.52M | 0.03% |
90,329
+1,494
| +2% | +$90.5K |
|
315
ServiceNow
NOW
$129B
| $5.52M | 0.03% |
26,865
-3,560
| -12% | -$672K |
|
316
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
| $5.52M | 0.03% |
24,464
-227
| -0.9% | -$47K |
|
|
NMAR
317
Innovator Growth-100 Power Buffer ETF - March
NMAR
$94.3M
| $5.46M | 0.03% |
197,719
+87,095
| +79% | +$2.27M |
|
318
McCormick & Company Non-Voting
MKC
$14.2B
| $5.46M | 0.03% |
71,982
-16,922
| -19% | -$1.27M |
|
319
Vertex Pharmaceuticals
VRTX
$126B
| $5.44M | 0.03% |
12,227
-2,100
| -15% | -$968K |
|
320
T. Rowe Price
TROW
$24.3B
| $5.43M | 0.03% |
56,265
-4,867
| -8% | -$447K |
|
321
AvalonBay Communities
AVB
$26.8B
| $5.41M | 0.03% |
26,356
+23,826
| +942% | +$4.87M |
|
322
Intel
INTC
$513B
| $5.34M | 0.03% |
238,482
-155,482
| -39% | -$3.22M |
|
323
Hershey
HSY
$36.6B
| $5.22M | 0.03% |
31,462
-3,775
| -11% | -$622K |
|
324
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
| $5.2M | 0.03% |
62,655
-23,216
| -27% | -$1.89M |
|
325
Starbucks
SBUX
$120B
| $5.12M | 0.03% |
55,865
-18,988
| -25% | -$1.65M |
|
Similar funds
CHP
FAM
OAG
BA
Cresset Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Cresset Asset Management held 1,837 positions worth $20.1B, up 0.32% from $20.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Cresset Asset Management withdrew a net $1.95B in Q2 2025, closing 408 positions and reducing 946 holdings. Its most notable exit was Amedisys, an estimated $41.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Cresset Asset Management opened a new position in Eagle Capital Select Equity ETF worth $112M.
- Cresset Asset Management's largest Q2 2025 buy was Eagle Capital Select Equity ETF: 3,722,566 shares worth $112M.
- Cresset Asset Management added most to Avantis U.S. Quality ETF in Q2 2025, an estimated $48.4M increase.
- Cresset Asset Management's biggest Q2 2025 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $141M.
- Cresset Asset Management fully exited Amedisys in Q2 2025, selling an estimated $41.8M.
- Cresset Asset Management's ten largest holdings make up 45% of its $20.1B portfolio in Q2 2025.
- Cresset Asset Management opened 126 new positions and closed 408 in Q2 2025.
- Cresset Asset Management's portfolio value rose 0.32% quarter-over-quarter to $20.1B.
Based on Cresset Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.